Although previous results already supported a putative role of ADAMTS1 in GBM [22], the new availability of data of a relevant number of patients, such as the CGGA and TCGA GBM-LGG projects, allowed us to approach a deeper and relevant in silico-based assessment. This evidence concerns the gene ADAMTS1 and glioblastoma.